ENDRA Ptb Ratio vs Free Cash Flow Yield Analysis
NDRA Stock | USD 5.71 0.34 5.62% |
ENDRA Life financial indicator trend analysis is much more than just examining ENDRA Life Sciences latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether ENDRA Life Sciences is a good investment. Please check the relationship between ENDRA Life Ptb Ratio and its Free Cash Flow Yield accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in ENDRA Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
Ptb Ratio vs Free Cash Flow Yield
Ptb Ratio vs Free Cash Flow Yield Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of ENDRA Life Sciences Ptb Ratio account and Free Cash Flow Yield. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between ENDRA Life's Ptb Ratio and Free Cash Flow Yield is 0.5. Overlapping area represents the amount of variation of Ptb Ratio that can explain the historical movement of Free Cash Flow Yield in the same time period over historical financial statements of ENDRA Life Sciences, assuming nothing else is changed. The correlation between historical values of ENDRA Life's Ptb Ratio and Free Cash Flow Yield is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ptb Ratio of ENDRA Life Sciences are associated (or correlated) with its Free Cash Flow Yield. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Free Cash Flow Yield has no effect on the direction of Ptb Ratio i.e., ENDRA Life's Ptb Ratio and Free Cash Flow Yield go up and down completely randomly.
Correlation Coefficient | 0.5 |
Relationship Direction | Positive |
Relationship Strength | Weak |
Ptb Ratio
Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.Free Cash Flow Yield
A financial solvency ratio that compares the free cash flow per share a company is expected to earn against its market value per share, calculated as free cash flow per share divided by market price per share.Most indicators from ENDRA Life's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into ENDRA Life Sciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in ENDRA Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. At present, ENDRA Life's Issuance Of Capital Stock is projected to increase significantly based on the last few years of reporting. The current year's Sales General And Administrative To Revenue is expected to grow to 574.37, whereas Selling General Administrative is forecasted to decline to about 3.7 M.
2023 | 2024 (projected) | Non Recurring | 258.8K | 230.0K | Reconciled Depreciation | 282.0K | 180.8K |
ENDRA Life fundamental ratios Correlations
Click cells to compare fundamentals
ENDRA Life Account Relationship Matchups
High Positive Relationship
High Negative Relationship
ENDRA Life fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 7.2M | 8.8M | 12.9M | 9.3M | 6.8M | 6.6M | |
Other Current Liab | 430.1K | 430.8K | 488.1K | 909.1K | 340.4K | 357.6K | |
Total Current Liabilities | 2.1M | 986.7K | 1.5M | 1.7M | 903.1K | 1.2M | |
Total Stockholder Equity | 4.8M | 7.2M | 10.8M | 7.2M | 5.7M | 5.2M | |
Net Tangible Assets | 4.8M | 7.2M | 10.8M | 7.2M | 8.3M | 5.1M | |
Property Plant And Equipment Net | 641.2K | 551.3K | 774.5K | 741.5K | 465.9K | 510.7K | |
Net Debt | (5.5M) | (6.5M) | (8.8M) | (4.3M) | (2.4M) | (2.6M) | |
Retained Earnings | (45.2M) | (57.3M) | (68.7M) | (81.9M) | (91.9M) | (87.3M) | |
Accounts Payable | 1.3M | 402.9K | 791.1K | 614.0K | 360.4K | 569.7K | |
Cash | 6.2M | 7.2M | 9.5M | 4.9M | 2.8M | 4.7M | |
Non Current Assets Total | 641.2K | 551.3K | 780.5K | 747.5K | 3.7M | 3.9M | |
Cash And Short Term Investments | 6.2M | 7.2M | 9.5M | 4.9M | 2.8M | 4.7M | |
Common Stock Total Equity | 392.0 | 742.0 | 842.0 | 3.4K | 3.9K | 4.1K | |
Common Stock Shares Outstanding | 375.0K | 959.6K | 2.0M | 2.9M | 9.0M | 9.5M | |
Liabilities And Stockholders Equity | 7.2M | 8.8M | 12.9M | 9.3M | 6.8M | 6.6M | |
Capital Surpluse | 23.2M | 33.9M | 49.9M | 64.5M | 74.2M | 77.9M | |
Inventory | 113.4K | 589.6K | 1.3M | 2.6M | 2.6M | 2.8M | |
Other Current Assets | 130.7K | 396.8K | 2.7M | 992.9K | 198.9K | 189.0K | |
Other Stockholder Equity | 49.9M | 64.5M | 79.5M | 89.1M | 97.6M | 51.6M | |
Total Liab | 2.4M | 1.6M | 2.1M | 2.1M | 1.1M | 1.4M | |
Property Plant And Equipment Gross | 641.2K | 551.3K | 774.5K | 741.5K | 1.1M | 576.8K | |
Total Current Assets | 6.5M | 8.2M | 12.1M | 8.5M | 3.0M | 5.7M | |
Accumulated Other Comprehensive Income | 43.5K | 10.8K | 13.9K | 6.1K | 5.2K | 5.5K | |
Common Stock | 842.0 | 3.4K | 4.3K | 317.0 | 1.0K | 1.3K | |
Property Plant Equipment | 641.2K | 551.3K | 774.5K | 741.5K | 852.7K | 510.5K | |
Net Receivables | 116.7K | 390.8K | (1.3M) | (2.6M) | (2.4M) | (2.2M) | |
Non Current Liabilities Total | 342.8K | 609.0K | 546.6K | 365.9K | 192.1K | 251.3K | |
Short Long Term Debt Total | 707.1K | 685.5K | 679.0K | 546.6K | 394.4K | 452.9K | |
Short Term Debt | 364.3K | 153.0K | 264.7K | 180.7K | 202.3K | 211.5K | |
Net Invested Capital | 5.1M | 7.5M | 10.8M | 7.2M | 5.7M | 7.5M | |
Net Working Capital | 4.5M | 7.2M | 10.6M | 6.8M | 2.1M | 2.0M | |
Capital Stock | 843.0 | 3.4K | 4.3K | 318.0 | 1.0K | 1.9K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether ENDRA Life Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ENDRA Life's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Endra Life Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Endra Life Sciences Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in ENDRA Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ENDRA Life. If investors know ENDRA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ENDRA Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share -3 K | Return On Assets (0.61) | Return On Equity (1.20) |
The market value of ENDRA Life Sciences is measured differently than its book value, which is the value of ENDRA that is recorded on the company's balance sheet. Investors also form their own opinion of ENDRA Life's value that differs from its market value or its book value, called intrinsic value, which is ENDRA Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ENDRA Life's market value can be influenced by many factors that don't directly affect ENDRA Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ENDRA Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if ENDRA Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ENDRA Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.